+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Hemostasis & Tissue Sealing Agents Market Size, Share & Trends Analysis Report by Product (Topical Hemostat, Adhesive & Tissue Sealant), by Region (Europe, APAC, North America), and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 150 Pages
  • July 2022
  • Region: Global
  • Grand View Research
  • ID: 3640131
The global hemostasis & tissue sealing agents market size is expected to reach USD 14.48 billion by 2030. It is projected to register a CAGR of 8.8% during the forecast period. The agents have gained popularity over time due to their ability to prevent blood loss. The rapid growth of minimally invasive technology and the demand for faster recovery by patients are expected to promote market growth over the forecast period.According to the Centers for Disease Control and Prevention (CDC), approximately 150 million of the American population are currently suffering from at least one chronic condition, which leads to surgeries and even mortality at times.

An estimate over the rising incidence was made by the CDC, which concluded that over 48% of the entire American population is expected to suffer from chronic conditions.The market is expected to witness lucrative growth over the next seven years owing to an increase in product demand supported by the rising surgery volumes. Growth in the geriatric population and the prevalence of chronic conditions are also among the key factorsdriving the market. In December 2019, the Ethicon, a unit of Johnson & Johnson, launched its protein spray for blood-stopping, designed to quickly & efficiently control and seal off excessive bleeding during minimally invasive procedures and open surgeries.

During the COVID-19 pandemic, severe cases among patients infected by the virus have shown the tendency to develop septic shock and Acute Respiratory Distress Syndrome (ARDS), demanding special care in ICU, with residual chronic disability and poor long-term results. Among these patients in the ICU, Coagulopathy has been commonly noticed indicating underlying diseases and organ dysfunction. This has been one of the major contributing factors to the increasing demand for hemostasis & tissue sealing products.

Hemostasis & Tissue Sealing Agents Market Report Highlights

  • The market growth can be attributed to a rise in the global volume of surgeries and the applicability of the product across a variety of surgeries to avoid the occurrence of hypovolemic shock, thrombocytopenia, blood transfusions, and postoperative complications
  • The flowable hemostats segment is expected to witness a lucrative CAGR from 2022 to 2030. Flowable hemostats are a combination of active and mechanical agents
  • They function by blocking blood flow and also converting fibrinogen into fibrin for coagulation
  • Market participants are involved in technological advancements to ensure sustainability and regional presence
  • For instance, in July 2021, Medcura, Inc., a medical devices company, announced the launch of Rapid-Seal, an antibacterial, high-performance hemostatic gel, in partnership with ASO, LLC, a supplier, and manufacturer of first-aid products


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Hemostasis & Tissue Sealing Agents Market

What is the estimated value of the Global Hemostasis & Tissue Sealing Agents Market?

The Global Hemostasis & Tissue Sealing Agents Market was estimated to be valued at $7.38 Billion in 2022.

What is the growth rate of the Global Hemostasis & Tissue Sealing Agents Market?

The growth rate of the Global Hemostasis & Tissue Sealing Agents Market is 8.8%, with an estimated value of $14.48 Billion by 2030.

What is the forecasted size of the Global Hemostasis & Tissue Sealing Agents Market?

The Global Hemostasis & Tissue Sealing Agents Market is estimated to be worth $14.48 Billion by 2030.

Who are the key companies in the Global Hemostasis & Tissue Sealing Agents Market?

Key companies in the Global Hemostasis & Tissue Sealing Agents Market include Johnson & Johnson, CryoLife Inc., Advance Medical Solution (AMS) Group Plc., Cohera Medical Inc., Integra Life Sciences Corporation, Pfizer Inc., C R Bard Inc., Cohesion Technologies Inc. and Biomet Inc..

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Information procurement
1.2.1. Purchased database
1.2.2. internal database
1.2.3. Secondary sources & third party perspectives
1.2.4. Primary research
1.3. Information analysis
1.3.1. Data analysis models
1.4. Market formulation & data visualization
1.5. Data validation & publishing

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Hemostasis and Tissue Sealing Agents Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis
3.4. User perspective analysis
3.4.1. Consumer Behavior Analysis
3.4.2. Market Influencer Analysis
3.5. List of Key End-users
3.6. Regulatory Framework
3.6.1. Reimbursement framework
3.6.2. Standards & Compliances
3.7. Market Dynamics
3.7.1. Market Driver Analysis
3.7.1.1. Increasing incidence rate of chronic conditions
3.7.1.2. Applicability of products across multiple conditions
3.7.1.3. Growing geriatric population
3.7.2. Market Restraint Analysis
3.7.2.1. Stringent regulations and approvals
3.7.3. Industry Challenges
3.7.3.1. Associated complications
3.8. Hemostasis and Tissue Sealing Agents: Market Analysis Tools
3.8.1. Industry Analysis - Porter’s
3.8.1.1. Supplier Power
3.8.1.2. Buyer Power
3.8.1.3. Substitution Threat
3.8.1.4. Threat from new entrant
3.8.1.5. Competitive rivalry
3.8.2. PESTEL Analysis
3.8.2.1. Political Landscape
3.8.2.2. Environmental Landscape
3.8.2.3. Social Landscape
3.8.2.4. Technology Landscape
3.8.2.5. Legal Landscape
3.8.3. Major Deals & Strategic Alliances Analysis
3.8.3.1. Joint Ventures
3.8.3.2. Mergers & Acquisitions
3.8.3.3. Licensing & Partnership
3.8.3.4. Technology Collaborations
3.8.3.5. Strategic Divestments
3.8.4. Market Entry Strategies
3.8.5. Case Studies

Chapter 4. Hemostasis and Tissue Sealing Agents Market: Segment Analysis, By Product, 2017 - 2030 (USD Million)
4.1. Definitions & Scope
4.2. Component market share analysis, 2021 & 2030
4.3. Segment Dashboard
4.4. Global Hemostasis and Tissue Sealing Agents Market, By Product
4.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
4.5.1. Topical hemostats
4.5.1.1. Active
4.5.1.2. Mechanical
4.5.1.3. Flowable
4.5.2. Adhesive & tissue sealant
4.5.2.1. Synthetic
4.5.2.2. Natural
4.5.2.3. Adhesion barrier

Chapter 5. Hemostasis and Tissue Sealing Agents Market: Regional Market Analysis, By Region, 2017 - 2030 (USD Million)
5.1. Definitions & Scope
5.2. Regional market share analysis, 2021 & 2030
5.3. Regional Market Dashboard
5.4. Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
5.5. Regional Market Share and Leading Players, 2021
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
5.6. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
5.6.1. North America
5.6.2. Europe
5.6.3. Asia Pacific
5.6.4. Latin America
5.6.5. Middle East & Africa
5.7. Market Size, & Forecasts, Volume and Trend Analysis, 2022 to 2030:
5.8. North America
5.8.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
5.8.2. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
5.8.3. U.S.
5.8.3.1. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
5.8.4. Canada
5.8.4.1. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
5.9. Europe
5.9.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
5.9.2. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
5.9.3. Germany
5.9.3.1. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
5.9.4. U.K.
5.9.4.1. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
5.9.5. France
5.9.5.1. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
5.9.6. Italy
5.9.6.1. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
5.9.7. Spain
5.9.7.1. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
5.10. Asia Pacific
5.10.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
5.10.2. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
5.10.3. China
5.10.3.1. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
5.10.4. Japan
5.10.4.1. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
5.10.5. India
5.10.5.1. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
5.10.6. Thailand
5.10.6.1. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
5.10.7. South Korea
5.10.7.1. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
5.11. Latin America
5.11.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
5.11.2. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
5.11.3. Brazil
5.11.3.1. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
5.11.4. Mexico
5.11.4.1. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
5.11.5. Argentina
5.11.5.1. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
5.11.6. Colombia
5.11.6.1. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
5.12. Middle East and Africa
5.12.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
5.12.2. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
5.12.3. South Africa
5.12.3.1. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
5.12.4. Saudi Arabia
5.12.4.1. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
5.12.5. UAE
5.12.5.1. Market estimates and forecast, by product, 2017 - 2030 (USD Million)

Chapter 6. Hemostasis and Tissue Sealing Agents Market - Competitive Analysis
6.1. Recent developments & impact analysis, by key market participants
6.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company market share analysis, 2021
6.4. Public Companies
6.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
6.4.2. Company Market Share/Ranking, by region
6.4.3. Competitive Dashboard Analysis
6.4.3.1. Market Differentiators
6.4.3.2. Synergy Analysis: Major Deals & Strategic Alliances
6.5. Private Companies
6.5.1. List of key emerging companies’ /technology disruptors/innovators
6.5.2. Funding Outlook (Optional)
6.5.3. Regional network map
6.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
6.6. Supplier Ranking
6.7. Key companies profiled
6.7.1. Johnson & Johnson
6.7.1.1. Company Overview
6.7.1.2. Financial Performance
6.7.1.3. Product Benchmarking
6.7.1.4. Strategic Initiatives
6.7.2. CryoLife Inc.
6.7.2.1. Company Overview
6.7.2.2. Financial Performance
6.7.2.3. Product Benchmarking
6.7.2.4. Strategic Initiatives
6.7.3. Advance Medical Solution (AMS) Group Plc.
6.7.3.1. Company Overview
6.7.3.2. Financial Performance
6.7.3.3. Product Benchmarking
6.7.3.4. Strategic Initiatives
6.7.4. Cohera Medical Inc.
6.7.4.1. Company Overview
6.7.4.2. Financial Performance
6.7.4.3. Product Benchmarking
6.7.4.4. Strategic Initiatives
6.7.5. Integra Life Sciences Corporation
6.7.5.1. Company Overview
6.7.5.2. Financial Performance
6.7.5.3. Product Benchmarking
6.7.5.4. Strategic Initiatives
6.7.6. Pfizer Inc.
6.7.6.1. Company Overview
6.7.6.2. Financial Performance
6.7.6.3. Product Benchmarking
6.7.6.4. Strategic Initiatives
6.7.7. C R Bard Inc.
6.7.7.1. Company Overview
6.7.7.2. Financial Performance
6.7.7.3. Product Benchmarking
6.7.7.4. Strategic Initiatives
6.7.8. Cohesion Technologies Inc.
6.7.8.1. Company Overview
6.7.8.2. Financial Performance
6.7.8.3. Product Benchmarking
6.7.8.4. Strategic Initiatives
6.7.9. HyperBranch Medical Technology.
6.7.9.1. Company Overview
6.7.9.2. Financial Performance
6.7.9.3. Product Benchmarking
6.7.9.4. Strategic Initiatives
6.7.10. Biomet Inc.
6.7.10.1. Company Overview
6.7.10.2. Financial Performance
6.7.10.3. Product Benchmarking
6.7.10.4. Strategic Initiatives
6.7.11. Covidien Plc.
6.7.11.1. Company Overview
6.7.11.2. Financial Performance
6.7.11.3. Product Benchmarking
6.7.11.4. Strategic Initiatives
6.7.12. B Braun Medical Inc.
6.7.12.1. Company Overview
6.7.12.2. Financial Performance
6.7.12.3. Product Benchmarking
6.7.12.4. Strategic Initiatives
6.7.13. Smith & Nephew.
6.7.13.1. Company Overview
6.7.13.2. Financial Performance
6.7.13.3. Product Benchmarking
6.7.13.4. Strategic Initiatives

Chapter 7. KOL Commentary

List of Tables
Table 1 North America Hemostasis and Tissue Sealing Agents Market, by Product, 2017-2030 (USD Million)
Table 2 U.S. Hemostasis and Tissue Sealing Agents Market, by Product, 2017-2030 (USD Million)
Table 3 Canada Hemostasis and Tissue Sealing Agents Market, by Product, 2017-2030 (USD Million)
Table 4 Europe Hemostasis and Tissue Sealing Agents Market, by Product, 2017-2030 (USD Million)
Table 5 U.K. Hemostasis and Tissue Sealing Agents Market, by Product, 2017-2030 (USD Million)
Table 6 Germany Hemostasis and Tissue Sealing Agents Market, by Product, 2017-2030 (USD Million)
Table 7 France Hemostasis and Tissue Sealing Agents Market, by Product, 2017-2030 (USD Million)
Table 8 Italy Hemostasis and Tissue Sealing Agents Market, by Product, 2017-2030 (USD Million)
Table 9 Spain Hemostasis and Tissue Sealing Agents Market, by Product, 2017-2030 (USD Million)
Table 10 Asia Pacific Hemostasis and Tissue Sealing Agents Market, by Product, 2017-2030 (USD Million)
Table 11 Japan Hemostasis and Tissue Sealing Agents Market, by Product, 2017-2030 (USD Million)
Table 12 China Hemostasis and Tissue Sealing Agents Market, by Product, 2017-2030 (USD Million)
Table 13 India Hemostasis and Tissue Sealing Agents Market, by Product, 2017-2030 (USD Million)
Table 14 Thailand Hemostasis and Tissue Sealing Agents Market, by Product, 2017-2030 (USD Million)
Table 15 South Korea Hemostasis and Tissue Sealing Agents Market, by Product, 2017-2030 (USD Million)
Table 16 Latin America Hemostasis and Tissue Sealing Agents Market, by Product, 2017-2030 (USD Million)
Table 17 Brazil Hemostasis and Tissue Sealing Agents Market, by Product, 2017-2030 (USD Million)
Table 18 Mexico Hemostasis and Tissue Sealing Agents Market, by Product, 2017-2030 (USD Million)
Table 19 Argentina Hemostasis and Tissue Sealing Agents Market, by Product, 2017-2030 (USD Million)
Table 20 Colombia Hemostasis and Tissue Sealing Agents Market, by Product, 2017-2030 (USD Million)
Table 21 MEA Hemostasis and Tissue Sealing Agents Market, by Product, 2017-2030 (USD Million)
Table 22 South Africa Hemostasis and Tissue Sealing Agents Market, by Product, 2017-2030 (USD Million)
Table 23 Saudi Arabia Hemostasis and Tissue Sealing Agents Market, by Product, 2017-2030 (USD Million)
Table 24 UAE Hemostasis and Tissue Sealing Agents Market, by Product, 2017-2030 (USD Million)

List of Figures
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Global hemostasis and tissue sealing agents market segmentation
Figure 9 Global hemostasis and tissue sealing agents market, 2017-2030 (USD Million)
Figure 10 Hemostasis and tissue sealing agents market dynamics
Figure 11 Number of individuals in the U.S. with a chronic condition (Estimates in Millions)
Figure 12 Rising geriatric population, by geography, (% increase)
Figure 13 Key opportunities prioritized
Figure 14 Hemostasis and tissue sealing agents market Porter’s analysis
Figure 15 Hemostasis and tissue sealing agents company market share, 2021
Figure 16 Hemostasis and tissue sealing agents market PESTEL analysis
Figure 17 Hemostasis and tissue sealing agents market share, by product, 2022 & 2030
Figure 18 Topical hemostats market, 2017-2030 (USD Million)
Figure 19 Active hemostats market, 2017-2030 (USD Million)
Figure 20 Mechanical hemostats market, 2017-2030 (USD Million)
Figure 21 Flowable hemostats market, 2017-2030 (USD Million)
Figure 22 Adhesives and tissue sealants market, 2017-2030 (USD Million)
Figure 23 Synthetic tissue sealants market, 2017-2030 (USD Million)
Figure 24 Natural tissue sealants market, 2017-2030 (USD Million)
Figure 25 Adhesion barrier products market, 2017-2030 (USD Million)
Figure 26 Hemostasis and tissue sealing agents market share, by region, 2021 & 2030
Figure 27 North America hemostasis and tissue sealing agents market, 2017-2030 (USD Million)
Figure 28 U.S. hemostasis and tissue sealing agents market, 2017-2030 (USD Million)
Figure 29 Canada hemostasis and tissue sealing agents market, 2017-2030 (USD Million)
Figure 30 Europe hemostasis and tissue sealing agents market, 2017-2030 (USD Million)
Figure 31 U.K. hemostasis and tissue sealing agents market, 2017-2030 (USD Million)
Figure 32 Germany hemostasis and tissue sealing agents market, 2017-2030 (USD Million)
Figure 33 France hemostasis and tissue sealing agents market, 2017-2030 (USD Million)
Figure 34 Italy hemostasis and tissue sealing agents market, 2017-2030 (USD Million)
Figure 35 Spain hemostasis and tissue sealing agents market, 2017-2030 (USD Million)
Figure 36 Asia Pacific hemostasis and tissue sealing agents market, 2017-2030 (USD Million)
Figure 37 Japan hemostasis and tissue sealing agents market, 2017-2030 (USD Million)
Figure 38 China hemostasis and tissue sealing agents market, 2017-2030 (USD Million)
Figure 39 Thailand hemostasis and tissue sealing agents market, 2017-2030 (USD Million)
Figure 40 South Korea hemostasis and tissue sealing agents market, 2017-2030 (USD Million)
Figure 41 India hemostasis and tissue sealing agents market, 2017-2030 (USD Million)
Figure 42 Latin America hemostasis and tissue sealing agents market, 2017-2030 (USD Million)
Figure 43 Brazil hemostasis and tissue sealing agents market, 2017-2030 (USD Million)
Figure 44 Mexico hemostasis and tissue sealing agents market, 2017-2030 (USD Million)
Figure 45 Argentina hemostasis and tissue sealing agents market, 2017-2030 (USD Million)
Figure 46 Colombia hemostasis and tissue sealing agents market, 2017-2030 (USD Million)
Figure 47 MEA hemostasis and tissue sealing agents market, 2017-2030 (USD Million)
Figure 48 South Africa hemostasis and tissue sealing agents market, 2017-2030 (USD Million)
Figure 49 Saudi Arabia hemostasis and tissue sealing agents market, 2017-2030 (USD Million)
Figure 50 UAE hemostasis and tissue sealing agents market, 2017-2030 (USD Million)

Companies Mentioned

  • Johnson & Johnson
  • CryoLife Inc.
  • Advance Medical Solution (AMS) Group Plc.
  • Cohera Medical Inc.
  • Integra Life Sciences Corporation
  • Pfizer Inc.
  • C R Bard Inc.
  • Cohesion Technologies Inc.
  • HyperBranch Medical Technology.
  • Biomet Inc.
  • Covidien Plc.
  • B Braun Medical Inc.
  • Smith & Nephew.

Methodology

Loading
LOADING...